Table 1.
Distribution of clinical characteristics of treatment and survival in 176 glioblastoma patients from Sweden and Denmark
| Sweden (n = 108) |
Denmark (n = 68) |
Total (n = 176) |
||||
|---|---|---|---|---|---|---|
| Total (n [%]) | Missing (n [%]) | Total (n [%]) | Missing (n [%]) | Total (n [%]) | Missing (n [%]) | |
| Survival (mos) | ||||||
| Mean | 16.1 | 15.1 | 15.7 | |||
| Median (range) | 12.4 (2.1–71.8) | 14.2 (1.0–51.9) | 12.8 (1.0–71.8) | |||
| Gross total resection | 6 (5.6) | 1 (1.5) | 169 (96.0) | 7 (4.0) | ||
| Yes | 26 (24.1) | 24 (35.3) | 50 (29.6) | |||
| No | 76 (70.4) | 43 (63.2) | 119 (70.4) | |||
| Chemotherapy | 13 (12.0) | 10 (14.7) | 153 (86.9) | 23 (13.1) | ||
| Yes | 69 (63.9) | 14 (20.6) | 83 (54.2) | |||
| No | 26 (24.1) | 44 (64.7) | 70 (45.8) | |||
| Radiotherapy | 7 (6.5) | 2 (2.9) | 167 (94.9) | 9 (5.1) | ||
| Yes | 90 (83.3) | 57 (83.8) | 147 (88.0) | |||
| No | 11 (10.2) | 9 (13.2) | 20 (12.0) | |||
| Number of deaths | 92 (85.2) | 10 (9.3) | 66 (97.1) | 158 (89.8) | 10 (5.7) | |
| Sex | 176 (100) | |||||
| Male | 66 (61.1) | 43 (63.2) | 109 (61.9) | |||
| Female | 42 (38.9) | 25 (36.8) | 67 (38.1) | |||
| Age at diagnosis median (yrs) | 56 (22–69) | 56 (39–69) | 56 (22–69) | |||